Financials IHH Healthcare Singapore S.E.

Equities

Q0F

MYL5225OO007

Healthcare Facilities & Services

Market Closed - Singapore S.E. 07:13:24 05/07/2024 BST 5-day change 1st Jan Change
1.81 SGD 0.00% Intraday chart for IHH Healthcare +1.69% +4.62%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 47,994 48,275 64,568 54,774 53,106 55,660 - -
Enterprise Value (EV) 1 52,305 53,770 70,083 54,774 60,777 63,207 62,066 61,768
P/E ratio 104 x 242 x 36.3 x 36.6 x 18 x 30.3 x 28.1 x 25.1 x
Yield 0.73% 0.73% 0.82% - 3.08% 1.26% 1.33% 1.44%
Capitalization / Revenue 3.22 x 3.6 x 3.77 x 3.04 x 2.54 x 2.48 x 2.32 x 2.18 x
EV / Revenue 3.51 x 4.01 x 4.09 x 3.04 x 2.9 x 2.81 x 2.58 x 2.42 x
EV / EBITDA 15.8 x 18.7 x 16.4 x 13.5 x 13.1 x 12.5 x 11.5 x 10.7 x
EV / FCF 37.6 x 34.2 x 28 x - 32.2 x 29.5 x 25.3 x 18.4 x
FCF Yield 2.66% 2.92% 3.57% - 3.11% 3.39% 3.95% 5.42%
Price to Book 2.15 x 2.02 x 2.63 x - 1.82 x 1.81 x 1.77 x 1.66 x
Nbr of stocks (in thousands) 8,773,990 8,777,219 8,796,677 8,806,043 8,806,991 8,807,037 - -
Reference price 2 5.470 5.500 7.340 6.220 6.030 6.320 6.320 6.320
Announcement Date 28/02/20 26/02/21 23/02/22 28/02/23 29/02/24 - - -
1MYR in Million2MYR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 14,912 13,405 17,132 17,989 20,935 22,461 24,016 25,536
EBITDA 1 3,318 2,876 4,279 4,051 4,644 5,051 5,409 5,795
EBIT 1 1,962 1,479 2,795 2,260 3,133 3,376 3,686 3,991
Operating Margin 13.16% 11.03% 16.32% 12.57% 14.97% 15.03% 15.35% 15.63%
Earnings before Tax (EBT) 1 1,043 567.5 2,556 2,217 4,049 2,922 3,197 3,552
Net income 1 551.5 288.9 1,863 1,548 2,952 1,884 2,029 2,262
Net margin 3.7% 2.16% 10.87% 8.61% 14.1% 8.39% 8.45% 8.86%
EPS 2 0.0528 0.0227 0.2020 0.1699 0.3352 0.2086 0.2249 0.2521
Free Cash Flow 1 1,391 1,571 2,504 - 1,889 2,142 2,451 3,351
FCF margin 9.33% 11.72% 14.62% - 9.02% 9.54% 10.21% 13.12%
FCF Conversion (EBITDA) 41.92% 54.6% 58.52% - 40.67% 42.41% 45.32% 57.82%
FCF Conversion (Net income) 252.2% 543.67% 134.47% - 63.99% 113.72% 120.81% 148.13%
Dividend per Share 2 0.0400 0.0400 0.0600 - 0.1860 0.0799 0.0838 0.0910
Announcement Date 28/02/20 26/02/21 23/02/22 28/02/23 29/02/24 - - -
1MYR in Million2MYR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 4,471 4,163 4,374 4,595 4,857 5,142 4,674 5,826 5,293 5,955 4,101 5,884 6,273 5,764 5,764
EBITDA - - - - - 1,149 - - - - - - - - -
EBIT 1 791.2 686.6 632.7 652.7 324.3 780 666.7 1,004 682.6 951.6 594.5 825.1 802.4 982.3 982.3
Operating Margin 17.7% 16.49% 14.47% 14.2% 6.68% 15.17% 14.26% 17.23% 12.9% 15.98% 14.5% 14.02% 12.79% 17.04% 17.04%
Earnings before Tax (EBT) 1 684.2 621.1 878.5 513.3 204.2 1,793 542 1,013 701.6 930.6 709.2 744.5 673.9 825.3 825.3
Net income 1 453.6 493.3 612.1 251.8 191.3 1,391 301.8 532.1 727.5 768 437.4 472.8 402.1 505.7 505.7
Net margin 10.15% 11.85% 14% 5.48% 3.94% 27.04% 6.46% 9.13% 13.74% 12.9% 10.67% 8.04% 6.41% 8.77% 8.77%
EPS 2 0.0490 0.0535 0.0669 0.0278 0.0217 0.1579 0.0343 0.0604 0.0826 0.0872 0.0498 0.0538 0.0458 0.0576 0.0576
Dividend per Share 2 0.0600 - - - - - 0.0350 - - - 0.0239 0.0249 0.0269 0.0276 0.0276
Announcement Date 23/02/22 26/05/22 25/08/22 29/11/22 28/02/23 31/05/23 29/08/23 30/11/23 29/02/24 29/05/24 - - - - -
1MYR in Million2MYR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 4,311 5,496 5,515 - 7,671 7,546 6,405 6,108
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.299 x 1.911 x 1.289 x - 1.652 x 1.494 x 1.184 x 1.054 x
Free Cash Flow 1 1,391 1,571 2,504 - 1,889 2,142 2,451 3,351
ROE (net income / shareholders' equity) 3.78% 3% 7.68% - 4.63% 6.27% 6.47% 7.26%
ROA (Net income/ Total Assets) 2.04% 1.6% 4.14% - 2.59% 4.26% 4.33% 5.31%
Assets 1 26,978 18,055 45,022 - 113,831 44,233 46,848 42,614
Book Value Per Share 2 2.550 2.720 2.790 - 3.300 3.490 3.570 3.810
Cash Flow per Share 2 0.2800 0.2800 0.4000 - 0.4300 0.4100 0.4300 0.6800
Capex 1 1,057 874 1,027 - 1,871 2,420 2,074 2,174
Capex / Sales 7.09% 6.52% 6% - 8.94% 10.77% 8.64% 8.51%
Announcement Date 28/02/20 26/02/21 23/02/22 28/02/23 29/02/24 - - -
1MYR in Million2MYR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
6.32 MYR
Average target price
7.26 MYR
Spread / Average Target
+14.87%
Consensus